Childhood Langerhans cell histiocytosis: a disease with many faces

AKC Leung, JM Lam, KF Leong - World Journal of Pediatrics, 2019 - Springer
Background Langerhans cell histiocytosis (LCH) is a group of diseases characterized by the
proliferation and accumulation of Langerhans cells. Clinical presentations of LCH vary …

Update on pulmonary Langerhans cell histiocytosis

E Radzikowska - Frontiers in Medicine, 2021 - frontiersin.org
Pulmonary Langerhans cell (LC) histiocytosis (PLCH) has unknown cause and is a rare
neoplastic disorder characterized by the infiltration of lungs and various organs by bone …

Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis

J Chen, A Zhao, M Duan, H Cai, X Gao, T Liu, J Sun… - Leukemia, 2022 - nature.com
Histiocytosis are rare types of hematological tumors originating from dendritic cells or
macrophages. Comprehensive genomic analysis have uncovered a series of activating …

Molecular and clinicopathologic characterization of pediatric histiocytoses

Z Hélias‐Rodzewicz, J Donadieu… - American journal of …, 2023 - Wiley Online Library
The spectrum of somatic mutations in pediatric histiocytoses and their clinical implications
are not fully characterized, especially for non‐Langerhans cell histiocytosis (‐LCH) …

[HTML][HTML] Effectiveness and safety of dabrafenib in the treatment of 20 Chinese children with BRAFV600E-mutated Langerhans cell histiocytosis

Y Yang, D Wang, L Cui, HH Ma… - … : Official Journal of …, 2021 - synapse.koreamed.org
Purpose We sought to investigate the effectiveness and safety of dabrafenib in children with
BRAF V600E-mutated Langerhans cell histiocytosis (LCH). Materials and Methods A …

Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis

T Okamoto, Y Murata, D Hasegawa, M Yoshida… - Cancer …, 2023 - Wiley Online Library
Langerhans cell histiocytosis (LCH) is a rare neoplastic disorder characterized by
inflammatory lesions arising from the anomalous accumulation of pathogenic CD1a+ …

The triptych of mixed histiocytosis: a systematic review of 105 cases and proposed clinical classification

A Bonometti… - Leukemia & …, 2021 - Taylor & Francis
Histiocytoses are one of the ultimate diagnostic challenges that every physician face at least
once in his/her life. Giving their protean manifestation and differentiated therapeutic needs …

Adult Langerhans cell histiocytosis and the skeleton

D Georgakopoulou, AD Anastasilakis… - Journal of Clinical …, 2022 - mdpi.com
Langerhans cell histiocytosis (LCH) is a rare inflammatory neoplasia in which somatic
mutations in components of the MAPK/ERK pathway have been identified. Osseous …

Analysis of the BRAF and MAP2K1 mutations in patients with Langerhans cell histiocytosis in Japan

T Hayase, S Saito, Y Shioda, T Imamura… - International Journal of …, 2020 - Springer
In Langerhans cell histiocytosis (LCH), somatic gene mutations in the mitogen-activated
protein kinase pathway have been identified in more than 80% of cases in Western …

Absence of BRAFV600E immunohistochemical expression in sporadic odontogenic keratocyst, syndromic odontogenic keratocyst and orthokeratinized odontogenic …

KS Jain, K Bodhankar, RS Desai… - Journal of Oral …, 2020 - Wiley Online Library
Background Odontogenic keratocyst (OKC) is a unique developmental odontogenic cyst that
has the potential to behave aggressively and is associated with the nevoid basal cell …